Envoy Medical (COCH) Gross Profit (2022 - 2026)
Envoy Medical's Gross Profit history spans 5 years, with the latest figure at -$274000.0 for Q1 2026.
- On a quarterly basis, Gross Profit fell 52.22% to -$274000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.3 million, a 195.82% decrease, with the full-year FY2025 number at -$979000.0, down 89.36% from a year prior.
- Gross Profit hit -$274000.0 in Q1 2026 for Envoy Medical, up from -$482000.0 in the prior quarter.
- Over the last five years, Gross Profit for COCH hit a ceiling of $516000.0 in Q4 2024 and a floor of -$518000.0 in Q4 2022.
- Historically, Gross Profit has averaged -$220000.0 across 5 years, with a median of -$274000.0 in 2026.
- Biggest five-year swings in Gross Profit: plummeted 551.02% in 2023 and later surged 223.44% in 2024.
- Tracing COCH's Gross Profit over 5 years: stood at -$518000.0 in 2022, then rose by 19.31% to -$418000.0 in 2023, then surged by 223.44% to $516000.0 in 2024, then tumbled by 193.41% to -$482000.0 in 2025, then surged by 43.15% to -$274000.0 in 2026.
- Business Quant data shows Gross Profit for COCH at -$274000.0 in Q1 2026, -$482000.0 in Q4 2025, and -$363000.0 in Q3 2025.